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UK 
1. Introduction 
Advances in histological, biochemical, physiological and molecular biological assays, as well 
as in microscopy and image analysis have allowed multiple analyses in muscle tissue (1-5). 
Muscle biopsy is invaluable in providing a definitive diagnosis of a wide range of 
myopathies (muscular dystrophies, glycogen storage diseases, inflammatory myopathies 
and congenital myopathies) and denervating disorders and gives important information on 
the course of the disease, informs treatment, disease stage as well as prognosis. Results of 
histopathological analyses should then be interpreted in context of the clinical history, 
examination and laboratory serum markers (1;6). Furthermore, access to muscle tissue 
provides the opportunity to assess morphological characteristics such as fibre composition, 
fibre cross sectional area and capillarisation (e.g. in ageing muscle) (7-9) as well as mRNA, 
protein abundance and muscle enzyme activity (10). Ultrastructural analyses to gauge 
response to intervention can be performed (11) as can studies of physiological characteristics 
of muscle such as single fibre contraction properties (2;8). 
2. History of muscle biopsy 
Methodologies enabling the study of muscle tissue have relied on obtaining tissue through 
post mortem or open muscle biopsy techniques that require general anaesthesia. Although 
open muscle biopsy provides large specimens that enables direct visualization of disease 
distribution and can include a peripheral nerve, the technique involves co-ordination 
between surgical and anaesthetic colleagues, requires an inpatient bed stay and is therefore 
time and resource demanding. Moreover, this technique can result in significant scarring.  
Microscopic analysis of muscle obtained through percutaneous biopsy can be credited to the 
French Neurologist Guillaume-Benjamin-Amand Duchenne (1806-1875), lauded for 
describing muscular dystrophy amongst his many other accolades. Fuelled by his 
passionate interest in muscular diseases and electrophysiology, he constructed a needle 
possessing a trocar that made it possible to obtain muscle tissue and was the first clinician to 
perform percutaneous or ‘semi-open’ muscle biopsy in living subjects without anaesthesia 
(12). 
Numerous muscle biopsy needles have since been described (13;14). However, the 
percutaneous needle introduced by Bergstrom in 1962 (15), similar in characteristic to the 
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needle described by Duchenne, gained popularity through widespread use in diagnostic as 
well as research (study of normal muscle in relation to physiological change) purposes in 
both children and adults (3;4;16). Although continuously being refined (17;18), each iteration 
of the needle is true to its origins i.e. possess a sharp trocar, a cutting cannula that needs 
sharpening perhaps every 10 uses and a pushing rod to expel the tissue post biopsy (Figure 
1). Muscle yields obtained from the needle biopsy have been reported to vary from 25-75 mg 
(2) 70 - 140mg (4) and up to 143-293 mg after repeated sampling (19). 
An alternative instrument to the Bergstrom biopsy needle is the Weil-Blakesley conchotome 
(Figure 2) (20-22). This instrument, designed like a forcep was described by Henriksson in 
1979 (21) and consists of a sharp biting tip encompassing a hollow that can vary from 4-6 
mm in width. In similar fashion to the Bergstrom needle, it is inserted through a skin 
incision 5-10mm in length but does not require a sharp trocar to aid muscle penetration. In 
addition, its design allows controlled tissue penetration and offers a degree of 
manoeuvrability (22). These features allow biopsy on a wider range of muscles and permits 
sampling of muscle groups where the pressure required for the needle procedure to 
penetrate muscle may not be advisable because of overlying neurovascular or underlying 
bony structures e.g. at the tibialis anterior (22;23). An additional benefit is that, unlike the 
Bergstrom needle, the conchotome biting tip does not need regular sharpening and has been 
reported to maintain sharpness for up to 4 years (17). Muscle yields from the conchotome 
technique in the earliest report by Henriksson (21) ranged from 26 to 296mg. In our practice, 
muscle weights ranged at a comparable 20-290mg (24). 
3. Micro-biopsy 
The ‘semi-open’ techniques described above requiring an incision may be considered too 
painful and the potential for scarring may be off putting for some. Furthermore, semi-open 
techniques may be impractical to study time course responses to intervention e.g. exercise or 
drug administration. As a consequence, minimally invasive techniques such as micro-biopsy 
have been explored (19;25;26). The device used for skeletal muscle micro-biopsy is a version 
of the popular spring loaded one-handed automated biopsy systems used to perform 
biopsies of the breast, prostate, kidney or liver. The assembly consists of a disposable core 
biopsy needle e.g. 16G Magnum ® (Bard Ltd, UK) and an insertion cannula that will allow 
multiple biopsies to be performed via a single insertion site (Figure 3). The needle 
penetration depth can be pre-set by the operator after which release of a trigger unloads the 
spring and fires the needle into the muscle, excising a small piece of tissue. The validity of 
this method compared with the Bergstrom needle in histomorphometric analyses has been 
tested (19). 
The semi-open muscle biopsy and micro-biopsy techniques are common, simple and easily 
learned procedures that have superseded open muscle biopsy in clinical as well as research 
practice (4;6;17). Any potential risks are reduced if performed correctly and with strict 
attention to asepsis. Muscles that can be subject to biopsy include the deltoid, biceps, triceps, 
tibialis anterior, gastrocnemius, soleus and the sacrospinal muscles (3;22;23;27;28). However, 
the most common site for biopsy both in clinical and research practice is the outermost 
portion of the vastus lateralis. This site, approximately two-thirds down a line from the 
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anterior superior iliac spine to the patella is readily accessible and does not contain an 
overlying neurovascular bundle. Furthermore, extensive normative fibre histo-
morphometric data obtained from vastus lateralis biopsy exists in the literature that allows 
the recognition of normal and abnormal and facilitates comparison between studies (2;6). 
4. Vastus lateralis muscle biopsy (Figure 4)  
The biopsy technique using the Weil-Blakesley conchotome and the Bergstrom needle is 
described below. The technique for micro-biopsy is reviewed by Hayot et al (19); apart from 
the fact that a skin incision is not required, the procedure shares the same principle as for 
the conchotome and needle methods and is illustrated in Figure 5. 
Equipment needed for percutaneous muscle biopsy 
1. Weil-Blakesley conchotome with either 4mm or 6mm biting tip (Gebrüder Zepf 
Medizintechnik, Dürbheim, Germany) (Figure 2) or Bergstrom needle with either 4mm or 
6mm cutting trocar (Dixons surgical instruments Ltd, UK) (Figure 1) 
2. 10ml and 20ml syringes 
3. Scalpel size 11 
4. Sterile gauze squares and sterile saline-soaked gauze squares 
5. Sterile drape with adhesive aperture (Steri-Drape ™, 3M Health Care, USA) 
6. Chlorhexidine or iodine based skin disinfectant 
7. 5-10ml 2% Lidocaine without epinephrine 
8. Sterile 10ml Universal Container 
9. Quarter inch steri-strips 
10. Stretchable bandage and elastic tape for compression 
11. Ice 
Optional (dependent on planned analyses) 
1. Liquid nitrogen and suitable cryovials 
2. Isopentane cooled in liquid nitrogen 
3. Cork disc 
4. OTC mount 
5. Fixative e.g. formalin, 3% Glutaralhedyde/4% formaldehyde 
6. Dissecting microscope to orientate tissue sample so that sections with fibres in true 
cross-section can be obtained 
7. Suitable blunt edged forceps for post procedure tissue handling 
In the clinical setting, muscle biopsies are conducted based on patient symptoms and the 
distribution of muscular weakness and generally do not require standardised conditions but 
do require the biopsy site to be free of previous muscle injury, contractures or prior 
instrumentation/therapy e.g. injection sites (1;6). In research or in quantitative studies, 
standard conditions should apply to all procedures. For example, studies may require 
participants to be fasted pre biopsy or the exclusion of diabetic subjects (24). 
There is little guidance on the use of aspirin or other anti-platelet agents pre biopsy. 
Whereas warfarin and related anticoagulants would need to be stopped for at least one to 
two weeks prior to the procedure, aspirin was stopped 4-7 days prior to uneventful muscle  
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Fig. 1. A. Components of the biopsy needle include 1. Trocar, 2. Cutting cannula, 3. Clearing 
probe/rod. B. Assembled for biopsy, with cutting cannula inserted within the trocar. A 20 
ml syringe can be connected to the cutting cannula to increase the yield of tissue by suction. 
C. Cutting window visible. D. Window with cutting cannula fully depressed. 
biopsy in our research study (24). It is likely that the drug free duration would need to be 
longer for ADP receptor blockers e.g. clopidogrel. Obviously, risks of stopping such 
secondary prevention drugs must be considered case-by-case. 
Participants are asked to lay supine, comfortably on a bed with the preferred thigh exposed 
from the groin crease. The operator should be positioned adjacent to the thigh however, a 
position adjacent to the contra-lateral thigh with the operator reaching over can also be 
assumed according to individual preference. The leg should remain straight and relaxed 
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Fig. 2. The Weil-Blakelsley Cochotome with a 6mm bitting tip (From Patel HP et al [24]) 
 
Fig. 3. Spring loaded micro-biopsy system consisting of trigger housing, biopsy needle and 
the insertion cannula (not shown). (Illustration kindly provided by M Hayot, Service Central de 
Physiologie Clinique, Montpellier, France)  
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A. The leg is exposed from the groin crease down to the ankle. B The biopsy area, approximately 2/3 
down a line from the anterior superior iliac spine to the patella is marked. C&D The biopsy site over 
the vastus lateralis is shaved of hair, infiltrated with local anaesthetic and cleaned with antiseptic. 
E. The biopsy site is isolated with a sterile drape that has a 10 cm adhesive aperture. F. The skin and 
overlying fascia is then punctured with a size 11 scalpel. The conchotome tip is inserted into the track 
made by the scalpel, opened, closed and rotated through 90 to excise tissue. G&H. The 5-10mm 
wound is closed with steri-strips after which a dry dressing and compression bandage are applied. 
Fig. 4. The muscle biopsy procedure using the Weil-Blakesley conchotome  
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A. Infiltration with local anaesthesia. B. Placement of biopsy needle into the trigger housing. C. Skin 
puncture with the insertion cannula. D. Insertion of the biopsy needle through the insertion cannula 
and trigger release. E. Removal of the of the muscle specimen aided by a sterile scalpel (insertion 
cannula can remain in situ to permit repeated sampling). F. Weighing of the sample. (Reproduced with 
permission of the European Respiratory Society ©) 
Fig. 5. Micro-biopsy procedure with the Magnum ® biopsy system (Bard Ltd, UK)19  
throughout the procedure but the thigh can be tensed momentarily to accentuate the outline 
of the vastus lateralis to mark the biopsy site. Thereafter the skin surrounding the mark is 




The skin and overlying fascia is then infiltrated with 5mls of 2% lidocaine local anaesthetic. 
The subcutaneous bleb is allowed to dissipate during which time the operator should dawn 
a sterile gown, gloves and create a sterile field on a suitable trolley. After opening the pack 
containing the Conchotome or biopsy needle, the skin should be sterilized with povidone 
iodine (Betadine) or a 2% Chlorhexidine gluconate/isopropyl alcohol solution according to 
local infection control protocols. A sterile drape with an adhesive aperture is then used to 
maintain a sterile field. With a size 11 scalpel, a 5-10mm incision is made on the skin and 
down to the fascia through which the closed biting tip of the conchotome is inserted. The 
conchotome is inserted at right angles to the long axis of the femur, facing away from the 
femur and to a depth averaging 2-5cm. The free hand of the operator can hold the thigh 
surrounding the biopsy site while the tip of the conchotome is opened and closed (scissor 
action) to interpose muscle tissue. The conchotome is then rotated through 90-180 to cut the 
muscle. Sampling takes a few seconds and can be repeated within the single site, where 
necessary, to obtain sufficient muscle tissue given the high probability of sampling adipose 
tissue initially (Figure 4 A-H). The biopsies should be placed on sterile saline-dampened 
gauze and then transferred into a universal container or petri dish and placed on ice for the 
remainder of the procedure. 
Operator and skin preparation prior to using the using the needle biopsy or the micro-
biopsy gun is exactly the same as described for the conchotome (17;29). Constituents of the 
needle include include the trocar/needle, the cutting cannula and the clearing probe/rod 
(Figure 1A 1,2,3 respectively). The instrument should be assembled by inserting the 
cutting cannula into the trocar and checked to ensure alignment and sliding action. The 
width of a size 11 scalpel to make a skin incision and a track down to the fascia should 
suffice. The trocar is inserted through the incision, past the fascia where the operator 
should get a sensation of overcoming resistance; at this point the window of the trocar 
(Figure 1C) should be fully in the muscle. The cutting cannula is withdrawn a few 
centimetres and the needle angled to allow tissue to enter the instrument. Alternatively, 
an assistant can apply suction via a syringe applied to the cutting cannula (Figure 1B) to 
draw muscle into the cutting chamber before fully advancing the cannula to guillotine a 
section of muscle (18;30) (Figure 1D) The free hand of the operator can be used to steady 
the thigh. The yield of muscle can be increased by rotating the instrument by 90 and 
repeating the procedure (18). 
Post procedure, direct pressure should be applied to the wound for 5-10 minutes prior to 
closure with steri-strips (Leukostrip, Smith and Nephew, UK). Sterile absorbent gauze is placed 
on the steri-strips and a clear adhesive film (Bioclusive™, Johnson and Johnson, UK) placed on 
the gauze. A two-layer compression bandage is then tied for up to 6 hours. The subject is 
asked to lay down for up to half an hour post procedure and is observed. The procedure, 
using the conchotome or the Bergstrom needle can take between 15 and 20 minutes; the 
majority of said time spent in preparation. 
4.1 Post muscle biopsy patient/participant advice 
Following the procedure it is common to experience some thigh stiffness that can be 
alleviated by gentle exercise e.g. walking. There are no real restrictions to mobility but in 
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our practice we ask participants to avoid 1. vigorous activity for 72 hours (hill climbing, 
running, heavy lifting) and 2. Immersion in water for 48-72 hours (24). Participants can 
shower if the biopsy site was protected from water for example, wrapping polythene 
plastic/cling film around the thigh. Written instructions for post biopsy care, spare 
dressings and emergency contact details should be given to each participant or patient. To 
ensure full wound healing, that can take up to two weeks, the dressing should be changed 
after 4 days and steri-strips removed at day 7 post procedure. All those having the 
procedure should be warned about transient numbness around the biopsy site that may 
persist for up to two weeks as well as the remote possibility of wound infection that would 
necessitate a medical consult.  
5. Acceptability and adverse events 
When performed correctly and according to protocol, the semi-open and micro-biopsy 
techniques result only in minor discomfort for the subject that is qualitatively described as a 
‘’pushing sensation” or a “deep pressure” (29) with very low pain scores (Table 1) (24). Post 
biopsy, there may be local soreness, stiffness or cramp that do not seem to limit normal 
activity including recreational sports e.g. golf, bowls (18;24) (Table 1). One participant in our 
research study reported running a Marathon two weeks after a conchotome vastus lateralis 
biopsy (24). 
Where authors have reported complications, they have commonly been wound 





VAS pain score (mm) Median (IQR) 
During the procedure 7(1-34) 
1 day post procedure 4(0-16) 
7 days post procedure 1(0-4) 
  
Daily activity resumed N (%) 
After one day 60(65%) 
After 2 days 26(28%) 




Table 1. Pain visual analogue scale (VAS) score and resumption of daily activity in 93 
research participants subject to the conchotome muscle biopsy. Pain scale was marked at 
0mm -‘no pain’ and at 100mm – ‘pain as bad as it can be’. Typically pain scores were low 
during and post procedure. The majority of the participants resumed daily activity one-day 




biopsy (20) or did not follow post biopsy recommendations and put an undue amount of 
strain onto the thigh shortly after the procedure (22). Pain only occurs if the fascia is 
caught in the needle or a nerve is sampled inadvertently and may persist for one to two 
weeks (6). There have been no reports in the literature of serious wound infections or 
disability post procedure.  
Minimally invasive muscle biopsy techniques described above are both feasible and 
acceptable in clinical and research practice with good safety profiles. The choice of 
instrument depends on experience and preference, tissue requirement, location of muscle as 
well as clinical assessment of disease involvement. When performed correctly, all yield 
muscle tissue satisfactory for most histochemical and histological analyses. In addition, the 
semi-open techniques allow detailed morphological, biochemical and molecular biological 
analyses to be conducted on muscle tissue. 
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